http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102648921-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e6adc8977de392c55e7e3b7f85a5ea2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2012-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4063f5d5cdd6dfb10a9082d73be081b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b731fa4a29ef4864e087df9e47fb8bec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fe1f1e933580038c544feaae47754e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bde12f477ead17ee4addd40b5bb45fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56e6e1ded81e4e1d0ebf615f40253a88 |
| publicationDate | 2014-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102648921-B |
| titleOfInvention | Medicinal combination for treating non-small cell lung cancer |
| abstract | The invention relates to a medicinal combination for treating non-small cell lung cancer. The medicinal combination consists of arsenic trioxide and gefitinib. The invention also relates to an application of the medicinal combination in preparation of a medicine for treating the non-small cell lung cancer. The medicinal combination for treating the non-small cell lung cancer has the advantages as follows: a combined targeting therapeutic method of the non-small cell lung cancer is researched; the medicinal combination of the arsenic trioxide and the gefitinib and the application of the medicinal combination is the preparation of the medicine for treating the non-small cell lung cancer are put forth for the first time; and combined application of an arsenical and the gefitinib in treatment of the non-small cell lung cancer is a very promising strategy and can benefit more patients suffering from the non-small cell lung cancer. |
| priorityDate | 2012-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.